Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Development of a Pharmacogenomic Panel for Early Detection of Chemotherapy- and Immunotherapy-Induced Cardiotoxicity.

NCT07663357 is registered in ClinicalTrials.gov with Beneficência Portuguesa de São Paulo as lead sponsor.

NCT NCT07663357
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07663357 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Development of a Pharmacogenomic Panel for Early Detection of Chemotherapy- and Immunotherapy-Induced Cardiotoxicity.
Lead sponsor
Beneficência Portuguesa de São Paulo
Phase
Observational
Overall status
Recruiting
Start date
May 11, 2026
Completion date
December 30, 2029
Enrollment
1,000 (estimated)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

cardiotoxicity